About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Portland | 9,744 Studies Near You

Clinical TrialsPortland

Clinical Trials in Portland

Discover 9,744 clinical trials near Portland, Oregon. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1161-1180 of 9,744 trials

Active not recruitingA Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in adult participants with perennial allergic rhinitis.NCT06339008·Huntington Beach, California and 73 others

Find Trials by Condition in Portland

Breast Cancerin Portland Lung Cancerin Portland Prostate Cancerin Portland Colorectal Cancerin Portland Melanomain Portland Leukemiain Portland Lymphomain Portland Pancreatic Cancerin Portland Ovarian Cancerin Portland Brain Cancerin Portland Diabetes

Data from ClinicalTrials.govTerms

WithdrawnA Study to Evaluate the Effectiveness of Voriconazole + Micafungin Versus Voriconazole Alone for Invasive AspergillosisTo evaluate the therapeutic effectiveness of voriconazole + micafungin versus voriconazole alone as primary therapy for invasive aspergillosis.NCT00423163·Birmingham, Alabama and 43 others

CompletedA Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)The overall objective is to study the safety, pharmacokinetics and efficacy of linsitinib (a small molecule IGF-1R inhibitor) administered orally twice daily (BID) vs. placebo, at…NCT05276063·Beverly Hills, California and 29 others

CompletedA Study In Adults With Moderate To Severe DermatomyositisA Study looking at Investigational drug and Placebo administered to adult Patients with moderate to severe DermatomyositisNCT03181893·Birmingham, Alabama and 40 others

CompletedZoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone InvolvementThis randomized phase III trial studies two different schedules of zoledronic acid to compare how well they work in reducing bone-related complications in patients with breast…NCT00869206·Fairbanks, Alaska and 503 others

CompletedS1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal CancerThis clinical trial studies the use of the financial impact assessment tool in patients with colorectal cancer that has spread from the primary site to other places in the body.NCT02728804·Anchorage, Alaska and 536 others

CompletedBipolar Study in Adults at Least 18 Years of AgeBipolar study of tolerability, clinical response and patient satisfactionNCT00067938·Albertville, Alabama and 307 others

TerminatedS0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED)RATIONALE: Drugs used in chemotherapy such as docetaxel use different ways to stop tumor cells from dividing so they stop growing or die.NCT00058448·Denver, Colorado and 48 others

CompletedS0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung CancerRATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00445848·Antioch, California and 152 others

Active not recruitingA Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CPThe study is designed to compare the efficacy of asciminib 80 mg QD versus Investigator selected Tyrosine Kinase Inhibitor (TKI) for the treatment of newly diagnosed, previously…NCT04971226·Denver, Colorado and 109 others

CompletedA Study of the Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing C-kit GeneIn the core study, participants with unresectable or metastatic gastrointestinal stromal tumors expressing c-kit were treated with either 400 mg or 600 mg imatinib mesylate for 3…NCT00237185·Boston, Massachusetts and 4 others

CompletedPhase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC PatientsThis is a Phase 2, multicenter, open-label, 3-arm, randomized, parallel group study to evaluate the efficacy and safety of TTX-030 with or without budigalimab in combination with…NCT06119217·Tucson, Arizona and 63 others

TerminatedS0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00045617·Mobile, Alabama and 99 others

Not yet recruitingPrecision T1D Platform - New Therapies for Cardio-Renal ComplicationsBreakthrough T1D has awarded support for a joint University of Michigan-Oregon Health \& Science University Center of Excellence (CoE) to address cardio-renal complications in T1D.NCT07594145·Ann Arbor, Michigan and 1 other

CompletedStudy to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent AsthmaThe purpose of this trial is to confirm the safety and clinical benefit of benralizumab administration in asthma patients with mild to moderate persistent asthma in order to gain…NCT02322775·Los Angeles, California and 56 others

CompletedUblituximab + Ibrutinib in Select B-cell MalignanciesThe purpose of this study is to evaluate the safety and effectiveness of Ublituximab in combination with Ibrutinib in patients with advanced hematologic malignancies.NCT02013128·Huntsville, Alabama and 17 others

CompletedEffect of Natalizumab on Infarct Volume in Acute Ischemic StrokeThe primary objective of the study is to determine whether one 300 mg dose of intravenous (IV) natalizumab reduces change in infarct volume from Baseline to Day 5 on magnetic…NCT01955707·San Diego, California and 49 others

CompletedLong-term Follow-up Study Designed to Evaluate the Relative Risk of Two Colonoscopy Schedules for Patients With Small PolypsColorectal cancer is a leading cause of cancer death in the United States.NCT00032344·Phoenix, Arizona and 12 others

CompletedMolecular Markers in Thyroid CancerThe purpose of this study is to evaluate how common gene mutations are in benign and malignant thyroid lesions.NCT00598364·Portland, Oregon

CompletedCombination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic MedulloblastomaThis phase II trial studies how well combination chemotherapy works in treating younger patients with newly diagnosed, non-metastatic desmoplastic medulloblastoma.NCT02017964·Birmingham, Alabama and 172 others

PreviousPage 59 of 488Next

in Portland

Heart Diseasein Portland